1. "Pediatrics, Department of"
Formats
  1. Journal Article (2874)
  2. Meeting Abstract (1908)
  3. Review (135)
  4. Book Section (123)
  5. Editorial (61)
  6. Conference Paper (53)
  7. Research Letter (33)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (11)
  11. Book Whole (4)
Groups
  1. Pediatrics, Department of (5250)
  2. Tow Center for Developmental Oncology (TCDO) (2073)
  3. GSK Faculty (1984)
  4. Center for Hematologic Malignancies (1906)
  5. Stem Cell Transplantation and Cellular Therapy Service (1636)
  6. Department of Medicine (1584)

More Groups

People
  1. Richard O'Reilly (748)
  2. Nai-Kong Cheung (648)
  3. Nancy Kernan (512)
  4. Michael La Quaglia (411)
  5. David Abramson (388)
  6. Ira Dunkel (371)

More People

Years
  1. 2025 (91)
  2. 2024 (231)
  3. 2023 (272)
  4. 2022 (332)
  5. 2021 (278)
  6. 2020 (323)

More Years

Publications
  1. Blood (608)
  2. Journal of Clinical Oncology (430)
  3. Pediatric Blood and Cancer (416)
  4. Biology of Blood and Marrow Transplantation (265)
  5. Neuro-Oncology (235)
  6. Cancer Research (129)

More Publications

Publishers
  1. American Society of Hematology (663)
  2. Elsevier Inc. (658)
  3. American Society of Clinical Oncology (463)
  4. Wiley Periodicals, Inc (430)
  5. Oxford University Press (338)
  6. American Association for Cancer Research (317)

More Publishers

Results (5250)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk factors and outcomes for hematotoxicity following tisagenlecleucel for pediatric B-acute lymphoblastic leukemia
    Meeting Abstract

    McNerney, K. O.; Fabrizio, V. A.; Talleur, A. C.; Lim, S. S.; Dreyzin, A.; Baggott, C.; Vatsayan, A.; Rossoff, J.; Prabhu, S.; Pacenta, H. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Results from an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin in patients with relapsed/refractory classic Hodgkin lymphoma: A trial of the ECOG-ACRIN Research Group (E4412)
    Meeting Abstract

    Diefenbach, C. S.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Forlenza, C. J.; Cole, P. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Progression-free survival (PFS) and toxicity with nivolumab-AVD compared to brentuximab vedotin-AVD in pediatric advanced stage (AS) classic Hodgkin lymphoma (cHL), results of SWOG S1826
    Meeting Abstract

    Castellino, S. M.; Li, H.; Herrera, A. F.; Punnett, A.; Leblanc, M.; Parsons, S. K.; Hodgson, D.; Keller, F.; Drachtman, R. A.; Lamble, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of venetoclax and selinexor in combination with chemotherapy in pediatric and young adult patients with relapsed or refractory acute myeloid leukemia: SELCLAX
    Meeting Abstract

    Zarnegar-Lumley, S.; Karol, S. E.; Pounds, S.; Klco, J. M.; Sulis, M. L.; Kuo, D. J.; Heym, K. M.; Ludwig, K.; Stevens, A. M.; Alexander, T. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pembrolizumab (pembro) in children and young adults with low-risk classical Hodgkin lymphoma (cHL) with slow early response (SER) to front-line chemotherapy (chemo): Early results from the phase 2 KEYNOTE-667 study
    Meeting Abstract

    Roth, L. G.; Keller, F.; Toledo, M. M.; Castellino, S. M.; Forlenza, C. J.; Catalan, M. A.; Krystal, J.; Lamble, A.; Rao, A. V.; Morales, F. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Aplastic anemia patients have diverse T cell repertoires and flexible T cell responses similar to healthy individuals
    Meeting Abstract

    Hu, A. C.; Kumar, S.; Enache, A. B. S.; Dulmovits, B. M.; Shah, Y. B.; Meng, W. Z.; Oved, J. H.; Carreno, B. M.; Prak, E. T. L.; Olson, T. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bacterial and bacteriophage consortia are associated with protective intestinal immunomodulatory metabolites in allogeneic stem cell transplantation patients
    Meeting Abstract

    Thiele Orberg, E.; Meedt, E.; Hiergeist, A.; Xue, J.; Heinrich, P.; Ghimire, S.; Miltiadous, O.; Lindner, S.; Schwarz, A.; Janssen, K. P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Rabbit antithymocyte (rATG) exposure and outcomes after hematopoietic cell transplantation: A real world experience from BMT CTN 1202
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Hosszu, K. K.; McAvoy, D.; Stewart, V.; Schmidt, G.; Levine, J.; Perales, M. A.; Giralt, S. A.; Baker, K. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial
    Meeting Abstract

    Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • High progression-free survival with low relapse rates after double-unit cord blood transplantation in patients with high-risk AML
    Meeting Abstract

    Politikos, I.; Fingrut, W. B.; Brown, S.; Chinapen, S.; Quach, S.; Dahi, P. B.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; more...
    Blood (2023)

    Fulltext@MSK | Save